Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 29, 2022Circulation Genomic and Precision MedicineOpen Access

Cost-Effectiveness of Polygenic Risk Scores to Guide Statin Therapy for Cardiovascular Disease Prevention

View Full Paper
Ask AI
Bookmark
Share

Authors

MKMichel KiflenALAnn LeSMShihong Mao

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kiflen et al. (2022) studied this question.

synapsesocial.com/papers/6a71cc20f44fa9f079df7fd1https://doi.org/10.1161/circgen.121.003423
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The rise of the genome and personalised medicine2017 · 205 citations
  2. 2Impact of Disability Status on Ischemic Stroke Costs in Canada in the First Year2012 · 133 citations
  3. 3Association of Statin Adherence With Mortality in Patients With Atherosclerotic Cardiovascular Disease2019 · 353 citations